Evidence map›Paper›PMID 41760299›Full record

ArticleIn vivo (Athens, Greece)

Negative Regulator of Interferon Response Promotes Toll-like Receptor 3-induced Interleukin 6 in Rheumatoid Synoviocyte.

Kairo Wada, Tadaatsu Imaizumi, Hikaru Kristi Ishibashi, Yuzuru Nakamura, Tatsuro Saruga, Shogo Kawaguchi, Mayuki Tachizaki, Kazuki Oishi, Eiji Sasaki, Kanichiro Wada and 1 more

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kairo WadaDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan; wadakai0909@outlook.jp.
Tadaatsu ImaizumiDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Hikaru Kristi IshibashiDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Yuzuru NakamuraDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Tatsuro SarugaDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Shogo KawaguchiDepartment of Vascular and Inflammatory Medicine, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Mayuki TachizakiDepartment of Vascular and Inflammatory Medicine, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Kazuki OishiDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Eiji SasakiDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Kanichiro WadaDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Yasuyuki IshibashiDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimRheumatoid arthritis (RA) is an autoimmune disease, with synovial inflammation as an important symptom. However, the pathogenesis of RA has not been fully elucidated. Long noncoding RNAs play a role in various biological and pathological situations, and negative regulators of interferon response ( MATERIALS AND

methodsCultured human rheumatoid fibroblast-like synoviocytes (RFLS) were treated with a synthetic Toll-like receptor 3 (TLR3) ligand, polyinosinic:polycytidylic acid (poly I:C). Expression of

resultsTreatment of cultured RFLS with poly I:C induced the expression of

conclusion

Indexed as

Arthritis, RheumatoidInterferonsInterleukin-6SynoviocytesToll-Like Receptor 3Cells, CulturedFibroblastsGene Expression RegulationHumansNF-kappa BPoly I-CSignal TransductionToll-Like Receptor AgonistsTranscription Factor RelAInterferonsInterleukin-6NF-kappa BPoly I-CTLR3 protein, humanToll-Like Receptor 3Toll-Like Receptor AgonistsTranscription Factor RelAIFN-βIL-6NF-kBNRIRRFLSTLR3

Identifiers

PMID41760299
PMCPMC12949919

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.